Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis
Whether it is our Liposomal Glutathione or our support for healthy ageing through the Healthy Aging Supplements collection, every decision is made with the goal of increasing bioavailability
Weight loss injections like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) have raised important questions about reproductive health
Research published in Diabetes, Obesity and Metabolism found that people lost 17.3 percent of their body weight when they used a GLP-1 agonist
By analyzing data from over 27,000 participants, our team has identified specific genetic variants ($GLP1R$ and $GIPR$) that predict how an individual will respond to medications like semaglutide and tirzepatide
DPP-4 is expressed in human pancreatic beta cells and its direct inhibition improves beta cell function and survival in type 2 diabetes